Quantinno Capital Management LP grew its holdings in Innospec Inc. (NASDAQ:IOSP) by 100.0% in the 1st quarter, HoldingsChannel.com reports. The fund owned 9,280 shares of the specialty chemicals company’s stock after purchasing an additional 4,640 shares during the quarter. Innospec comprises 0.5% of Quantinno Capital Management LP’s portfolio, making the stock its 29th biggest holding. Quantinno Capital Management LP’s holdings in Innospec were worth $773,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Avestar Capital LLC acquired a new position in shares of Innospec in the first quarter valued at $66,000. LS Investment Advisors LLC raised its stake in shares of Innospec by 173.5% in the fourth quarter. LS Investment Advisors LLC now owns 1,972 shares of the specialty chemicals company’s stock valued at $122,000 after purchasing an additional 1,251 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Innospec by 27.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,986 shares of the specialty chemicals company’s stock valued at $123,000 after purchasing an additional 428 shares in the last quarter. US Bancorp DE raised its stake in shares of Innospec by 54.6% in the first quarter. US Bancorp DE now owns 1,764 shares of the specialty chemicals company’s stock valued at $147,000 after purchasing an additional 623 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in shares of Innospec by 74.6% in the first quarter. PNC Financial Services Group Inc. now owns 2,357 shares of the specialty chemicals company’s stock valued at $197,000 after purchasing an additional 1,007 shares in the last quarter. 93.34% of the stock is owned by institutional investors.

Innospec stock traded up $0.04 during mid-day trading on Friday, hitting $85.65. 107,094 shares of the company were exchanged, compared to its average volume of 87,492. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.28 and a quick ratio of 1.45. Innospec Inc. has a 1-year low of $53.07 and a 1-year high of $88.84. The firm has a market capitalization of $2.10 billion, a P/E ratio of 17.73 and a beta of 1.28.

Innospec (NASDAQ:IOSP) last released its quarterly earnings data on Tuesday, May 7th. The specialty chemicals company reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.07. Innospec had a return on equity of 14.92% and a net margin of 6.08%. The firm had revenue of $388.30 million during the quarter. During the same quarter in the prior year, the company earned $1.02 earnings per share. The business’s revenue was up 7.7% compared to the same quarter last year. On average, equities research analysts predict that Innospec Inc. will post 5.15 EPS for the current fiscal year.

The business also recently disclosed a Semi-Annual dividend, which was paid on Thursday, May 30th. Shareholders of record on Tuesday, May 21st were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a yield of 1.18%. Innospec’s dividend payout ratio is currently 20.70%.

In other Innospec news, VP Catherine Hessner sold 2,000 shares of the stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $83.64, for a total transaction of $167,280.00. Following the completion of the transaction, the vice president now directly owns 20,923 shares in the company, valued at $1,749,999.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold 4,300 shares of company stock valued at $356,236 over the last quarter. Corporate insiders own 1.62% of the company’s stock.

A number of research analysts recently commented on the company. BidaskClub upgraded Innospec from a “buy” rating to a “strong-buy” rating in a research note on Thursday, May 9th. ValuEngine upgraded Innospec from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Finally, Zacks Investment Research lowered Innospec from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 30th.

COPYRIGHT VIOLATION NOTICE: “Quantinno Capital Management LP Boosts Stake in Innospec Inc. (NASDAQ:IOSP)” was published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.watchlistnews.com/quantinno-capital-management-lp-boosts-stake-in-innospec-inc-nasdaqiosp/3042667.html.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.

Read More: What does an equal weight rating mean?

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.